Protective nasal spray, of which Near East University is a project and patent partner, has been made available by IKAS Pharma under the brand name Olirin in TRNC.
Near East University has launched the protective nasal spray, of which it is a project partner, in the TRNC under the brand name Olirin, in order to prevent the transmission of SARS-CoV-19, which causes COVID-2, to cells.
Olirin, which can be administered through the nose and mouth, on the one hand prevents SARS-CoV-2 from binding to the cells in the upper respiratory tract, on the other hand, it provides dual protection by killing viruses with its antiviral effect. Olirin is also effective against viruses other than SARS-CoV-2.
Developed in partnership with Near East University, Perugia University, European Biotechnology Association (EBTNA) and Italian MAGI Group, the spray was started to be used in the fight against COVID-2021 in Italy in February 19. Olirin, whose production and distribution rights in the TRNC, Turkey and Turkic Republics belong to the Near East Initiative, is planned to be made available in Turkey in the near future.
Olirin is in pharmacies with the assurance of IKAS Pharma
Protective spray Olirin, produced from completely natural ingredients, is a product with natural ingredients, obtained from olive leaf extract. For this reason, the brand selection was inspired by the word “olive”, which means olive in English.
İKAS Pharma, which has reached a wide pharmaceutical portfolio with its innovative vision and agreements with many leading companies and manufacturers, will carry out the distribution of Olirin in the TRNC, although it has been only two years since its establishment. İKAS Pharma, which distributes Olirin to pharmacies in the TRNC, will soon bring the product to users in Turkey through all pharmacies and online sales sites.
Protective Nasal Spray Developed by Near East University against COVID-19 is in Pharmacies with Olirin Brand! Dr. İrfan Suat Günsel: “We are happy to introduce Olirin, which will make a significant contribution to the fight against COVID-19, for use in our country.”
Expressing his happiness in presenting the protective spray, of which Near East University is a project and patent partner by taking part in the development phase, to the use of the TRNC people with his own brands, Chairman of the Board of Trustees of the Near East Incorporation Prof. Dr. İrfan Suat Günsel said, “We are proud to present the protective spray, which was born as an international project in the fight against COVID-19 and of which we are an important part, for the use of our people with our own brand. We want to crown our pride by making Olirin available in Turkey soon," he said.
Stating that Olirin is a very important indicator of the scientific competence of the Near East University and the vision of University 4.0, Prof. Dr. Günsel said, “I would like to thank the very valuable scientists of our university who contributed from the development of Olirin to the production phase.”
prof. Dr. Tamer Şanlıdağ: “Olirin provides two-way protection against viruses” Near East University Acting Rector Prof. Dr. Tamer Şanlıdağ emphasized that the protective Olirin, as a product with natural components, prevents SARS-CoV-19, which causes COVID-2, from binding to cells, and on the other hand, it provides double-sided protection by killing viruses with its antiviral effect. Stating that the vaccination process, which is applied rapidly in the world, is extremely important in controlling COVID-19, Prof. Dr. Tamer Şanlıdağ said that Olirin will make an important contribution to this process as an effective personal protection product. prof. Dr. Şanlıdağ also made the evaluation that “Olirin is a product that provides the same protection not only against SARS-CoV-2 but also against many viruses”.
Assoc. Dr. Mahmut Çerkez Ergören: “Olirin, which inactivates SARS-CoV-2, has no side effects” Assoc. Dr. Mahmut Çerkez Ergören said, “Research and experiments have revealed that Olirin does not cause toxic effects in cells, it inactivates SARS-CoV-19 and does not cause side effects.”
Hasan Kölel: “We will bring Olirin, which we have made available through pharmacies in the TRNC, to users through all pharmacies and online sales sites in Turkey.” İKAS Pharma General Manager Hasan Kölel said that they have distributed Olirin to all contracted pharmacies in the TRNC and made it available to the public as of today. It is a great pride,” he said. Kölel said that they plan to introduce Olirin, which is distributed to pharmacies in the TRNC, to users in all pharmacies and online sales sites in Turkey in the near future.
Be the first to comment